These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9725552)

  • 1. Atorvastatin does not produce a clinically significant effect on the pharmacokinetics of terfenadine.
    Stern RH; Smithers JA; Olson SC
    J Clin Pharmacol; 1998 Aug; 38(8):753-7. PubMed ID: 9725552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.
    Shimizu M; Uno T; Sugawara K; Tateishi T
    Br J Clin Pharmacol; 2006 May; 61(5):538-44. PubMed ID: 16669847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics.
    Yasui-Furukori N; Uno T; Sugawara K; Tateishi T
    Clin Pharmacol Ther; 2005 Jan; 77(1):17-23. PubMed ID: 15637527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
    Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
    Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C; Gupta S; Marino M; Lim J; Affrime M
    Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics.
    Stangier J; Rathgen K; Stähle H; Reseski K; Körnicke T; Roth W
    Am J Cardiovasc Drugs; 2009; 9(1):59-68. PubMed ID: 19178132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus.
    Kovarik JM; Hartmann S; Hubert M; Berthier S; Schneider W; Rosenkranz B; Rordorf C
    J Clin Pharmacol; 2002 Feb; 42(2):222-8. PubMed ID: 11831546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.
    Hoch M; Hoever P; Theodor R; Dingemanse J
    Eur J Clin Pharmacol; 2013 Jun; 69(6):1235-45. PubMed ID: 23334403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of rifampin administration on the disposition of fexofenadine.
    Hamman MA; Bruce MA; Haehner-Daniels BD; Hall SD
    Clin Pharmacol Ther; 2001 Mar; 69(3):114-21. PubMed ID: 11240975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromycin coadministration increases plasma atorvastatin concentrations.
    Siedlik PH; Olson SC; Yang BB; Stern RH
    J Clin Pharmacol; 1999 May; 39(5):501-4. PubMed ID: 10234598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of venlafaxine on the pharmacokinetics of terfenadine.
    Amchin J; Zarycranski W; Taylor KP; Albano D; Klockowski PM
    Psychopharmacol Bull; 1998; 34(3):383-9. PubMed ID: 9803772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxetine does not affect the cardiac safety and pharmacokinetics of terfenadine in healthy adult men.
    Martin DE; Zussman BD; Everitt DE; Benincosa LJ; Etheredge RC; Jorkasky DK
    J Clin Psychopharmacol; 1997 Dec; 17(6):451-9. PubMed ID: 9408807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole alters the pharmacokinetics of atorvastatin to a greater extent than either cerivastatin or pravastatin.
    Mazzu AL; Lasseter KC; Shamblen EC; Agarwal V; Lettieri J; Sundaresen P
    Clin Pharmacol Ther; 2000 Oct; 68(4):391-400. PubMed ID: 11061579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the P-glycoprotein inducer carbamazepine on fexofenadine pharmacokinetics.
    Yamada S; Yasui-Furukori N; Akamine Y; Kaneko S; Uno T
    Ther Drug Monit; 2009 Dec; 31(6):764-8. PubMed ID: 19855315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atorvastatin on the pharmacokinetics of everolimus among kidney transplant recipients.
    Wanitchanont A; Somparn P; Vadcharavivad S; Chancharoenthana W; Townamchai N; Praditpornsilpa K; Avihingsanon Y
    Transplant Proc; 2014; 46(2):418-21. PubMed ID: 24655978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine.
    Honig PK; Wortham DC; Lazarev A; Cantilena LR
    J Clin Pharmacol; 1996 Apr; 36(4):345-51. PubMed ID: 8728348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grapefruit juice increases serum concentrations of atorvastatin and has no effect on pravastatin.
    Lilja JJ; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Aug; 66(2):118-27. PubMed ID: 10460065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice.
    Clifford CP; Adams DA; Murray S; Taylor GW; Wilkins MR; Boobis AR; Davies DS
    Eur J Clin Pharmacol; 1997; 52(4):311-5. PubMed ID: 9248771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic and pharmacodynamic interaction between zileuton and terfenadine.
    Awni WM; Cavanaugh JH; Leese P; Kasier J; Cao G; Locke CS; Dube LM
    Eur J Clin Pharmacol; 1997; 52(1):49-54. PubMed ID: 9143867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.